Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
2018 · Journal of Hematology & Oncology · 389 citations
https://doi.org/10.1186/s13045-018-0578-4
X
Xiaolei Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
374
Papers
11.4K
Citations
51
h-index
150
i10-index
Xiaolei Li is an academic researcher from Kunming University of Science and Technology. The author has contributed to research in topics: Viral Infections and Immunology Research & Cancer, Hypoxia, and Metabolism & RNA modifications and cancer. The author has an h-index of 51, co-authored 318 publications.
ORCID: 0000-0002-2697-6496Papers by this author
worksHarnessing tumor-associated macrophages as aids for cancer immunotherapy
2019 · Molecular Cancer · 377 citations
https://doi.org/10.1186/s12943-019-1102-3
Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling
2016 · Cell Death and Disease · 234 citations
https://doi.org/10.1038/cddis.2015.407
HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression
2021 · Oncogene · 151 citations
https://doi.org/10.1038/s41388-020-01636-x
Spermidine endows macrophages anti-inflammatory properties by inducing mitochondrial superoxide-dependent AMPK activation, Hif-1α upregulation and autophagy
2020 · Free Radical Biology and Medicine · 140 citations
https://doi.org/10.1016/j.freeradbiomed.2020.10.029
Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
2016 · Scientific Reports · 122 citations
https://doi.org/10.1038/srep20484
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat